These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
86 related articles for article (PubMed ID: 2533860)
21. Arterial smooth muscle contractions in spontaneously hypertensive rats on a high-calcium diet. Pörsti I J Hypertens; 1992 Mar; 10(3):255-63. PubMed ID: 1315823 [TBL] [Abstract][Full Text] [Related]
22. Rapid large artery remodeling following the administration and withdrawal of calcium channel blockers in spontaneously hypertensive rats. Vaja V; Ochodnicky P; Krenek P; Klimas J; Bajuszova Z; Kyselovic J Eur J Pharmacol; 2009 Oct; 619(1-3):85-91. PubMed ID: 19683522 [TBL] [Abstract][Full Text] [Related]
23. Structural and functional adaptation in the rat myocardium and coronary vascular bed caused by changes in pressure and volume load. Friberg P Acta Physiol Scand Suppl; 1985; 540():1-47. PubMed ID: 3161269 [TBL] [Abstract][Full Text] [Related]
24. Antihypertensive effects of intravenous administration of benidipine hydrochloride and some other calcium antagonists in conscious, spontaneously hypertensive rats. Karasawa A; Kubo K; Oka T; Nakamizo N Arzneimittelforschung; 1988 Nov; 38(11A):1691-4. PubMed ID: 3219141 [TBL] [Abstract][Full Text] [Related]
25. Exposure to a moderate intensity static magnetic field enhances the hypotensive effect of a calcium channel blocker in spontaneously hypertensive rats. Okano H; Ohkubo C Bioelectromagnetics; 2005 Dec; 26(8):611-23. PubMed ID: 16189831 [TBL] [Abstract][Full Text] [Related]
26. A comparative study of morphological changes in spontaneously hypertensive rats and normotensive Wistar Kyoto rats treated with an angiotensin-converting enzyme inhibitor or a calcium-channel blocker. Saleh FH; Jurjus AR J Pathol; 2001 Mar; 193(3):415-20. PubMed ID: 11241424 [TBL] [Abstract][Full Text] [Related]
27. Transient AT1 receptor-inhibition in prehypertensive spontaneously hypertensive rats results in maintained cardiac protection until advanced age. Baumann M; Janssen BJ; Hermans JJ; Peutz-Kootstra C; Witzke O; Smits JF; Struijker Boudier HA J Hypertens; 2007 Jan; 25(1):207-15. PubMed ID: 17143193 [TBL] [Abstract][Full Text] [Related]
28. Reduced hemodynamic load aids low-dose resveratrol in reversing cardiovascular defects in hypertensive rats. Thandapilly SJ; Louis XL; Behbahani J; Movahed A; Yu L; Fandrich R; Zhang S; Kardami E; Anderson HD; Netticadan T Hypertens Res; 2013 Oct; 36(10):866-72. PubMed ID: 23784505 [TBL] [Abstract][Full Text] [Related]
29. Effect of the new calcium antagonist (+/-)-(R*)-3-[(R*)-1-benzyl-3- piperidyl] methyl 1,4-dihydro-2,6-dimethyl-4-(m-nitrophenyl)-3,5- pyridinedicarboxylate hydrochloride (KW-3049) on cardiac hypertrophy in spontaneously hypertensive rats. Kato Y; Tanaka H; Saijyo T; Hattori O; Suzuki K; Hara T; Deguchi T J Toxicol Sci; 1993 Aug; 18 Suppl 3():21-31. PubMed ID: 7505033 [TBL] [Abstract][Full Text] [Related]
30. Effects of nilvadipine on regional cerebral blood flow and skin blood flow in anesthetized cats. Takakura S; Satoh Y; Satoh H; Mori J; Kohsaka M Arch Int Pharmacodyn Ther; 1992; 319():38-48. PubMed ID: 1285672 [TBL] [Abstract][Full Text] [Related]
31. Cardiovascular pharmacology of nicardipine in animals. Takenaka T; Asano M; Shiono K; Shibasaki M; Inagaki O Br J Clin Pharmacol; 1985; 20 Suppl 1(Suppl 1):7S-22S. PubMed ID: 4027153 [TBL] [Abstract][Full Text] [Related]
32. Resveratrol prevents the development of pathological cardiac hypertrophy and contractile dysfunction in the SHR without lowering blood pressure. Thandapilly SJ; Wojciechowski P; Behbahani J; Louis XL; Yu L; Juric D; Kopilas MA; Anderson HD; Netticadan T Am J Hypertens; 2010 Feb; 23(2):192-6. PubMed ID: 19942861 [TBL] [Abstract][Full Text] [Related]
33. Inhibitory effect of tranilast on hypertrophic collagen production in the spontaneously hypertensive rat heart. Umemura K; Kikuchi S; Suzuki Y; Nakashima M Jpn J Pharmacol; 1998 Oct; 78(2):161-7. PubMed ID: 9829619 [TBL] [Abstract][Full Text] [Related]
34. Alterations in alpha subunit expression of cardiac Na+,K+-ATPase in spontaneously hypertensive rats: effect of antihypertensive therapy. Liu X; Songu-Mize E Eur J Pharmacol; 1997 May; 327(2-3):151-6. PubMed ID: 9200553 [TBL] [Abstract][Full Text] [Related]
35. Suppression of atherogenesis in cholesterol-fed rabbits treated with nilvadipine, a new vasoselective calcium entry blocker. Koibuchi Y; Sakai S; Miura S; Ono T; Shibayama F; Ohtsuka M Atherosclerosis; 1989 Oct; 79(2-3):147-55. PubMed ID: 2597224 [TBL] [Abstract][Full Text] [Related]
36. Lack of effect of anti-hypertensive treatment with felodipine on cardiovascular structure of young spontaneously hypertensive rats. Nyborg NC; Mulvany MJ Cardiovasc Res; 1985 Sep; 19(9):528-36. PubMed ID: 4042120 [TBL] [Abstract][Full Text] [Related]
37. Nicardipine and vascular hypertrophy. Amenta F; Bronzetti E; Ferrante F Am Heart J; 1991 Jul; 122(1 Pt 2):324-30. PubMed ID: 2053553 [TBL] [Abstract][Full Text] [Related]
38. Effect of different dihydropyridine-type Ca2+ antagonists on left ventricle hypertrophy and coronary changes in spontaneously hypertensive rats. Tomassoni D; Sabbatini M; Amenta F J Cardiovasc Pharmacol; 2003 Apr; 41(4):544-52. PubMed ID: 12658055 [TBL] [Abstract][Full Text] [Related]
39. Neuroprotective effect of treatment with calcium antagonists on hypertensive retina. Sabbatini M; Tomassoni D; Di Tullio MA; Amenta F Clin Exp Hypertens; 2002; 24(7-8):727-40. PubMed ID: 12450247 [TBL] [Abstract][Full Text] [Related]
40. Effect of nilvadipine on the development of neurological deficits in stroke-prone spontaneously hypertensive rats. Takakura S; Furuichi Y; Yamamoto T; Ogawa T; Satoh H; Mori J Stroke; 1994 Mar; 25(3):677-82; discussion 682-3. PubMed ID: 8128525 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]